BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16885985)

  • 1. Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.
    Jin H; Sperka T; Herrlich P; Morrison H
    Nature; 2006 Aug; 442(7102):576-9. PubMed ID: 16885985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins.
    Riecken LB; Zoch A; Wiehl U; Reichert S; Scholl I; Cui Y; Ziemer M; Anderegg U; Hagel C; Morrison H
    Oncotarget; 2016 Nov; 7(48):78242-78254. PubMed ID: 27793041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
    Laulajainen M; Muranen T; Carpén O; Grönholm M
    Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding light on Merlin's wizardry.
    Okada T; You L; Giancotti FG
    Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
    Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
    Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
    Horiguchi A; Zheng R; Shen R; Nanus DM
    Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.
    Jung JR; Kim H; Jeun SS; Lee JY; Koh EJ; Ji C
    Mol Cells; 2005 Oct; 20(2):196-200. PubMed ID: 16267393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merlin sumoylation is required for its tumor suppressor activity.
    Qi Q; Liu X; Brat DJ; Ye K
    Oncogene; 2014 Oct; 33(41):4893-903. PubMed ID: 24166499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional inactivation of NF2/merlin in human mesothelioma.
    Thurneysen C; Opitz I; Kurtz S; Weder W; Stahel RA; Felley-Bosco E
    Lung Cancer; 2009 May; 64(2):140-7. PubMed ID: 18835652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI; Haipek CA; Gutmann DH
    Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
    Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
    Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas.
    Xu J; Zhang Y; Shi Y; Yin D; Dai P; Zhao W; Zhang T
    Otol Neurotol; 2020 Jan; 41(1):e94-e102. PubMed ID: 31789805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
    Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
    Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merlin facilitates ubiquitination and degradation of transactivation-responsive RNA-binding protein.
    Lee JY; Moon HJ; Lee WK; Chun HJ; Han CW; Jeon YW; Lim Y; Kim YH; Yao TP; Lee KH; Jun TY; Rha HK; Kang JK
    Oncogene; 2006 Feb; 25(8):1143-52. PubMed ID: 16247459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining curcumin (diferuloylmethane) and heat shock protein inhibition for neurofibromatosis 2 treatment: analysis of response and resistance pathways.
    Angelo LS; Wu JY; Meng F; Sun M; Kopetz S; McCutcheon IE; Slopis JM; Kurzrock R
    Mol Cancer Ther; 2011 Nov; 10(11):2094-103. PubMed ID: 21903608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.
    Rong R; Tang X; Gutmann DH; Ye K
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18200-5. PubMed ID: 15598747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Yamauchi J; Miyamoto Y; Kusakawa S; Torii T; Mizutani R; Sanbe A; Nakajima H; Kiyokawa N; Tanoue A
    Exp Cell Res; 2008 Jul; 314(11-12):2279-88. PubMed ID: 18486129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
    Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
    Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin.
    Kim H; Lim JY; Kim YH; Kim H; Park SH; Lee KH; Han H; Jeun SS; Lee JH; Rha HK
    Mol Cells; 2002 Aug; 14(1):108-14. PubMed ID: 12243339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway.
    Cui Y; Ma L; Schacke S; Yin JC; Hsueh YP; Jin H; Morrison H
    Hum Mol Genet; 2021 Feb; 29(23):3793-3806. PubMed ID: 33331896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.